Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China flag China · Delayed Price · Currency is CNY
14.78
+0.04 (0.27%)
Feb 3, 2026, 1:04 PM CST

SHA:600535 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
22,02121,60325,42715,98823,77822,302
Market Cap Growth
2.36%-15.04%59.04%-32.76%6.62%-4.09%
Enterprise Value
19,58519,11624,80615,10323,39623,975
Last Close Price
14.7414.0815.849.8013.9812.74
PE Ratio
19.9322.6123.74-10.0819.81
Forward PE
12.6015.727.474.038.3012.53
PS Ratio
2.642.542.931.852.991.64
PB Ratio
1.761.782.001.261.791.80
P/TBV Ratio
1.911.912.161.341.931.92
P/FCF Ratio
17.8114.9013.348.5310.6716.13
P/OCF Ratio
12.9710.729.877.018.4912.45
PEG Ratio
-1.801.801.801.801.80
EV/Sales Ratio
2.352.252.861.752.941.77
EV/EBITDA Ratio
11.6910.4312.758.5114.2012.44
EV/EBIT Ratio
15.3813.3117.2211.2718.8317.28
EV/FCF Ratio
15.8413.1913.018.0510.4917.34
Debt / Equity Ratio
0.070.140.220.170.130.23
Debt / EBITDA Ratio
0.510.871.461.170.981.45
Debt / FCF Ratio
0.691.151.491.160.762.02
Asset Turnover
0.530.540.520.520.480.67
Inventory Turnover
1.751.621.762.041.854.16
Quick Ratio
3.072.342.913.544.102.73
Current Ratio
3.833.113.694.314.993.26
Return on Equity (ROE)
8.02%6.93%8.02%-2.68%18.74%8.99%
Return on Assets (ROA)
5.01%5.66%5.43%5.08%4.70%4.28%
Return on Invested Capital (ROIC)
10.67%10.98%11.22%12.28%9.04%6.67%
Return on Capital Employed (ROCE)
9.90%11.40%10.00%9.40%8.50%10.20%
Earnings Yield
4.99%4.42%4.21%-1.65%9.92%5.05%
FCF Yield
5.61%6.71%7.50%11.73%9.38%6.20%
Dividend Yield
3.51%3.76%2.08%3.37%2.36%2.59%
Payout Ratio
75.77%109.09%52.59%-25.88%70.99%
Buyback Yield / Dilution
0.60%-0.43%-1.34%2.29%-0.08%1.06%
Total Shareholder Return
4.11%3.34%0.75%5.66%2.27%3.65%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.